ABL Bio Inc. (KOSDAQ:298380)
134,800
-7,200 (-5.07%)
Apr 30, 2026, 3:30 PM KST
100.30% (1Y)
| Market Cap | 7.55T +349.5% |
| Revenue (ttm) | 79.35B +137.6% |
| Net Income | -37.81B |
| EPS | -734.08 |
| Shares Out | 55.99M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 674,731 |
| Average Volume | 575,575 |
| Open | 140,000 |
| Previous Close | 142,000 |
| Day's Range | 134,100 - 140,600 |
| 52-Week Range | 57,700 - 257,500 |
| Beta | 0.34 |
| RSI | 36.38 |
| Earnings Date | May 13, 2026 |